Avinash Hosanagar, MD
- 3Articles
- 59.2KReads
- 2021–2024Active
- 12Collaborators
- 22Citations
About
Avinash Hosanagar, MD, is affiliated with the Department of Psychiatry at the University of Michigan Medical School and the Mental Health Service at VA Ann Arbor Healthcare System. Hosanagar has published research on the clinical outcomes of intravenous ketamine treatment for depression within the VA health system and the therapeutic potential of psychedelics in psychiatric disorders, focusing on psychopharmacology, neurobiological effects, and evidence review. Collaborations frequently include Joseph Cusimano, Rajiv Radhakrishnan, Brian Martis, Dara Ganoczy, and Fe Erlita D. Festin.
Publications
Psychedelics and Treatment of Psychiatric Disorders, Part 1: Psychopharmacology and Neurobiological Effects
February 23, 2021
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.